CN1172711C - 治疗慢性结膜炎的中药制剂 - Google Patents
治疗慢性结膜炎的中药制剂 Download PDFInfo
- Publication number
- CN1172711C CN1172711C CNB021312508A CN02131250A CN1172711C CN 1172711 C CN1172711 C CN 1172711C CN B021312508 A CNB021312508 A CN B021312508A CN 02131250 A CN02131250 A CN 02131250A CN 1172711 C CN1172711 C CN 1172711C
- Authority
- CN
- China
- Prior art keywords
- preparation
- flos
- eye
- chinese medicine
- conjunctivitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 206010010741 Conjunctivitis Diseases 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 201000005547 chronic conjunctivitis Diseases 0.000 title claims abstract description 14
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 17
- 241001113925 Buddleja Species 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 24
- 229940079593 drug Drugs 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 20
- 244000293323 Cosmos caudatus Species 0.000 claims description 17
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 10
- 238000012546 transfer Methods 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 6
- 229960002216 methylparaben Drugs 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 230000007935 neutral effect Effects 0.000 claims description 5
- 235000011837 pasties Nutrition 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 238000001256 steam distillation Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 241000245240 Lonicera Species 0.000 claims description 2
- 235000014435 Mentha Nutrition 0.000 claims description 2
- 241001072983 Mentha Species 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims 3
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims 3
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims 3
- 239000003186 pharmaceutical solution Substances 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 33
- 239000003889 eye drop Substances 0.000 description 30
- 230000000694 effects Effects 0.000 description 20
- 238000000034 method Methods 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 13
- 241000283973 Oryctolagus cuniculus Species 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 210000000795 conjunctiva Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000000744 eyelid Anatomy 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 241000186216 Corynebacterium Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 241000475481 Nebula Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 241000607142 Salmonella Species 0.000 description 5
- 241001312524 Streptococcus viridans Species 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 4
- 241000201295 Euphrasia Species 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 241000191963 Staphylococcus epidermidis Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000003908 antipruritic agent Substances 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000001524 infective effect Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010014025 Ear swelling Diseases 0.000 description 2
- 241000150100 Margo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 229940097572 chloromycetin Drugs 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- CGSVCNBINHWWFW-UHFFFAOYSA-M dimethyl-(2-phenoxyethyl)-(thiophen-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C=1C=CSC=1C[N+](C)(C)CCOC1=CC=CC=C1 CGSVCNBINHWWFW-UHFFFAOYSA-M 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001111421 Pannus Species 0.000 description 1
- 241000167686 Reichardia Species 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 206010067130 Spastic diplegia Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940088529 claritin Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000000457 tarsus Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021312508A CN1172711C (zh) | 2002-09-19 | 2002-09-19 | 治疗慢性结膜炎的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021312508A CN1172711C (zh) | 2002-09-19 | 2002-09-19 | 治疗慢性结膜炎的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1400004A CN1400004A (zh) | 2003-03-05 |
CN1172711C true CN1172711C (zh) | 2004-10-27 |
Family
ID=4746610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021312508A Expired - Lifetime CN1172711C (zh) | 2002-09-19 | 2002-09-19 | 治疗慢性结膜炎的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1172711C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311842C (zh) * | 2005-08-18 | 2007-04-25 | 北京市眼科研究所 | 一种治疗慢性结膜炎的药物及其制备方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104306430B (zh) * | 2014-10-29 | 2015-10-28 | 东莞市达庆医疗器械有限公司 | 一种医用生物眼部冷疗敷料及其制备方法 |
CN106727957A (zh) * | 2017-03-06 | 2017-05-31 | 安徽省双科药业有限公司 | 一种金珍滴眼液中药提取工艺 |
CN106902152A (zh) * | 2017-03-06 | 2017-06-30 | 安徽省双科药业有限公司 | 一种抗久视疲劳的滴眼液及其生产工艺 |
CN111544390B (zh) * | 2020-05-21 | 2022-04-15 | 温州医科大学附属眼视光医院 | 治疗睑板腺功能障碍和/或过敏性结膜炎的中药制剂及超声雾化和纳米喷雾制剂和制备方法 |
CN115590919B (zh) * | 2022-09-23 | 2024-02-13 | 合肥立方制药股份有限公司 | 密蒙花及其提取物在制备人工泪液中的用途 |
-
2002
- 2002-09-19 CN CNB021312508A patent/CN1172711C/zh not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311842C (zh) * | 2005-08-18 | 2007-04-25 | 北京市眼科研究所 | 一种治疗慢性结膜炎的药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1400004A (zh) | 2003-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1113599C (zh) | 单纯性疱疹病毒和其它感染性疾病的抗微生物疗法 | |
CN1772081A (zh) | 一种治疗腹泻病的中药组合物 | |
CN1456344A (zh) | 一种治疗咽喉炎的药物组合物及其制备方法 | |
CN1172711C (zh) | 治疗慢性结膜炎的中药制剂 | |
CN105106318B (zh) | 一种治疗干眼症的中药组合物及其制备方法 | |
CN1772136A (zh) | 一种用于治疗筋腱软组织损伤及骨关节病的药物组合物及制备方法 | |
CN107912463A (zh) | 一种中西结合杀菌消毒液及制备方法 | |
CN109394987A (zh) | 含富马酸二甲酯的具有治疗眼部疾病功效的组合物及其制备方法 | |
CN1056298C (zh) | 一种治疗软组织损伤的外用药及其生产方法 | |
CN100337658C (zh) | 治疗感冒风热症的中药组合物及其制备方法 | |
CN1293913C (zh) | 一种治疗急慢性咽炎的中药袋泡茶剂及其生产方法 | |
CN1899553A (zh) | 治疗牙齿敏感证的糊剂及其制备方法 | |
CN1259080C (zh) | 一种抗菌、抗病毒、抗炎作用的滴眼液及其制备方法 | |
CN1065764C (zh) | 速效止痛灵擦剂及其制备方法 | |
CN106924448B (zh) | 治疗风热感冒的药物组合物及其制备方法 | |
CN104306764B (zh) | 一种用于治鼻炎的中药复方喷剂 | |
CN100341546C (zh) | 一种抗单纯疱疹病毒的药物组合物及其制备方法 | |
CN112263607B (zh) | 一种治疗睑缘炎的外用中药组合物及其制备方法和用途 | |
CN1698794A (zh) | 一种含挥发油成分的药物组合物的制备和应用 | |
CN100339116C (zh) | 咸味清咽润喉含片 | |
CN105902842A (zh) | 一种新型治疗眼睛疲劳的护眼膏药及其制备方法 | |
Badarudin | EXPLORING THE TRADITIONAL THERAPY FOR CATARACT BASED ON THE MALAY MEDICAL MANUSCRIPT: A SCOPING REVIEW | |
CN105943611A (zh) | 一种治疗青光眼的药物 | |
CN110170024A (zh) | 一种治疗颈椎病的药物组合物及其制备方法 | |
CN104706744B (zh) | 一种中药组合物及其应用与制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicine preparation for curing chronic conjunctivitis Effective date of registration: 20180323 Granted publication date: 20041027 Pledgee: Bank of Communications Ltd. Anhui branch Pledgor: ANHUI SHUANGKE PHARMACEUTICAL CO.,LTD. Registration number: 2018340000084 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190628 Granted publication date: 20041027 Pledgee: Bank of Communications Ltd. Anhui branch Pledgor: ANHUI SHUANGKE PHARMACEUTICAL CO.,LTD. Registration number: 2018340000084 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicine preparation for curing chronic conjunctivitis Effective date of registration: 20190705 Granted publication date: 20041027 Pledgee: Bank of Communications Ltd. Anhui branch Pledgor: ANHUI SHUANGKE PHARMACEUTICAL CO.,LTD. Registration number: 2019340000363 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201124 Address after: 100000 No. 1 East Lane, Beijing, Dongcheng District Patentee after: BEIJING TONGREN HOSPITAL, CAPITAL MEDICAL University Address before: 230088 No. 669 Changjiang West Road, Hefei, Anhui Patentee before: ANHUI SHUANGKE PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211221 Granted publication date: 20041027 Pledgee: Bank of Communications Ltd. Anhui branch Pledgor: ANHUI SHUANGKE PHARMACEUTICAL CO.,LTD. Registration number: 2019340000363 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20041027 |
|
CX01 | Expiry of patent term |